Daejeon, South Korea

Yong Ho Ahn

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Yong Ho Ahn in Antibody Production

Introduction

Yong Ho Ahn is a prominent inventor based in Daejeon, South Korea, known for his significant contributions to the field of biotechnology, particularly in antibody production. With a total of six patents, Ahn has developed innovative techniques that enhance the efficiency and quality of antibody expression.

Latest Patents

Ahn's recent patents include groundbreaking advancements in antibody expression technology. One of his notable inventions is a bicistronic expression vector designed for effective antibody expression. This vector comprises a first expression cassette that features a promoter, UTR, intron, antibody light chain gene, and polyA sequence, alongside a second cassette containing similar components for the antibody heavy chain gene and an internal ribosome entry site (IRES). This innovative method allows for the construction of expression vectors capable of producing antibodies with high efficiency while maintaining stability during the culturing of transfected animal cells.

Another significant patent involves a method for preparing antibodies with regulated sugar chain content. This method utilizes a medium that includes glycerol as an additive to control the sugar content of antibodies during the culturing process. This approach not only allows for the preparation of a high-quality population of antibodies but also enhances the development of biosimilars, achieving high equivalence to control drugs. The simplicity and efficiency of this method make it highly applicable in the fields of antibody preparation.

Career Highlights

Throughout his career, Yong Ho Ahn has collaborated with various notable companies in the biotechnology sector, including Ares Trading S.A. and Prestige Biopharma Pte. Ltd. His work has consistently focused on innovative solutions that address challenges associated with antibody production and quality control, helping advance therapeutic applications.

Collaborations

Ahn has worked alongside esteemed colleagues such as Sang Kyung Park and Soo Kwang Kim, contributing to a collaborative environment that fosters innovation in biopharmaceutical development. These partnerships have allowed for the sharing of expertise and resources, ultimately enhancing the impact of their patented technologies.

Conclusion

Yong Ho Ahn's contributions to the field of antibody production are marked by his innovative patents, which enhance both efficacy and quality. His work has helped pave the way for advanced therapeutic solutions, and his ongoing collaborations with industry professionals continue to drive progress in biotechnology. As the field evolves, Ahn's inventions will undoubtedly play a critical role in shaping the future of antibody production and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…